Aug 25 (Reuters) - MannKind Corp ( MNKD ):
* MANNKIND TO ACQUIRE SCPHARMACEUTICALS, ACCELERATING
REVENUE
GROWTH AND EMERGING AS A PATIENT-CENTRIC LEADER IN
CARDIOMETABOLIC AND LUNG DISEASES
* MANNKIND CORP ( MNKD ) - DEAL FOR UPFRONT CASH PAYMENT OF $5.35 PER
SHARE
PLUS CVR
* MANNKIND CORP ( MNKD ) - TOTAL EQUITY VALUE $303 MILLION, DEAL
VALUE UP
TO $360 MILLION
* MANNKIND CORP ( MNKD ) - CO AND BLACKSTONE AMEND FINANCING
AGREEMENT FOR
$175 MILLION
Source text:
Further company coverage: